Search results
Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers -...
WFRV 5 Green Bay· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the"Company") (NASDAQ: BIIB) and certain officers. The class action, filed in the United States ...
Poll: Texans’ support for marijuana reforms at all-time high
San Antonio Express-News· 7 hours agoPublic support for cannabis in the Lone Star State is at an all-time high — 73% of Texas adults...
Ascension Wisconsin patients navigate uncertainty, delays and faxes in cyberattack's wake
Gannett via AOL· 6 days agoBut the appointment was canceled. She was told May 8 she would get a callback, but a week later, she has...but says she is in a "terrifying" place. Everything she has read about MS has emphasized ...
Duchenne Muscular Dystrophy (DMD) Treatment
Verywell Health via Yahoo News· 6 days agoAt the current time, gene therapy can help improve symptoms of DMD and delay disease progression, but it is not a cure. Additionally, gene therapy is not...
Lupus expert debunks 7 common myths about the autoimmune disease: ‘Not a death sentence’
Fox News· 2 days agoFatigue, pain, swelling, rashes and hair loss are just some of the symptoms that affect people with...
Marinus Pharmaceuticals completes TrustTSC trial enrollment By Investing.com
Investing.com· 6 days agoThe trial is evaluating the effectiveness of oral ganaxolone in treating seizures associated with...
Progentos launches with $65M for MS drug development - Boston Business Journal
The Business Journals· 3 days agoFueled by $65 million in funding, a Watertown startup is launching with the intention to tackle ...
Biogen is buying up an immune drug developer for $1.8 billion
Quartz· 2 days agoBiogen has agreed to a $1.15 billion upfront payment and up to $650 million in additional payments...
Biogen shares maintain overweight rating By Investing.com
Investing.com· 2 days agoThe firm reiterated an Overweight rating on the stock, alongside a price target of $331.00. This...
Nightmares May Have an Eerie Link to Autoimmune Disease
ScienceAlert via Yahoo News· 2 days agoBut for the roughly 40 percent who do, diagnosis and treatment is challenging, as symptoms like nightmares and hallucinations are subjective and many patients are hesitant ...